A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste
一项针对COVID-19门诊患者早期治疗的口服卡莫司他甲磺酸盐的II期随机、双盲、安慰剂对照试验显示，该药物可缩短病程并减轻嗅觉和味觉丧失。
期刊:
影响因子:
doi:10.1101/2022.01.28.22270035
Chupp, Geoffrey; Spichler-Moffarah, Anne; Søgaard, Ole S; Esserman, Denise; Dziura, James; Danzig, Lisa; Chaurasia, Reetika; Patra, Kailash P; Salovey, Aryeh; Nunez, Angela; May, Jeanine; Astorino, Lauren; Patel, Amisha; Halene, Stephanie; Wang, Jianhui; Hui, Pei; Patel, Prashant; Lu, Jing; Li, Fangyong; Gan, Geliang; Parziale, Stephen; Katsovich, Lily; Desir, Gary V; Vinetz, Joseph M
